Search Results - "oligonucleotide"
Suggested Topics within your search.
Suggested Topics within your search.
- Medicine 9
- Biology, life sciences 6
- Chemistry 4
- Research & information: general 4
- Technology: general issues 3
- Materials science 2
- Medical genetics 2
- Medicine: general issues 2
- Oncology 2
- Psychotherapy 2
- Biomaterials 1
- Biotechnology 1
- Inorganic chemistry 1
- Microbiology (non-medical) 1
- Molecular biology 1
- Neurosciences 1
- Nucleic Acid 1
- Nucleic acids 1
- Pharmaceutical industries 1
- Pharmacology 1
- Science: general issues 1
- Therapeutics 1
-
281
Drug Delivery of siRNA Therapeutics
Published 2020Subjects: “…oligonucleotide delivery…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
282
Nanotechnology to Overcome World's Most Critical Health Issues: Liposomes and beyond-a Themed Issue Dedicated to Professor Yechezkel Barenholz
Published 2023Subjects: “…morpholino oligonucleotides…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
283
Peptide Nucleic Acids Applications in Biomedical Sciences
Published 2020Subjects: “…oligonucleotides…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
284
Strategies to Enhance Drug Permeability across Biological Barriers
Published 2023Subjects: “…oligonucleotide…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
285
Carotenoids
Published 2019Subjects: “…antisense oligonucleotide…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
286
Molecular Therapies for Inherited Retinal Diseases
Published 2020Subjects: “…gapmer antisense oligonucleotides…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
287
The Role of Toll-Like Receptors (TLR) in Infection and Inflammation
Published 2023Subjects: “…oligonucleotide…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
288
New Insights on Biofilm Antimicrobial Strategies, 2nd Volume
Published 2022Subjects: “…antisense oligonucleotides…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
289
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology
Published 2020Subjects: “…antisense oligonucleotide…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
290
Biomimetic Radical Chemistry and Applications 2021
Published 2022Subjects: “…oligonucleotides…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
291
Preclinical Evaluation of Lipid-Based Nanosystems
Published 2021Subjects: “…oligonucleotide…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
292
Novel Anticancer Strategies
Published 2023Subjects: “…antisense oligonucleotides…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
293
Novel Anticancer Strategies (Volume II)
Published 2023Subjects: “…oligonucleotide therapeutics…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
294
Biomimetic Radical Chemistry and Applications
Published 2020Subjects: “…oligonucleotides…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
295
Advances in Nanomaterials in Biomedicine
Published 2021Subjects: “…amphiphilic oligonucleotides…”
DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter -
296
-
297
-
298
-
299
Antisense RNA Design, Delivery, and Analysis
Published 2022Table of Contents: “…Introduction and History of the Chemistry of Nucleic Acids Therapeutics -- Antisense RNA Therapeutics: A Brief Overview -- Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion -- Design and Delivery of SINEUP: A New Modular Tool to Increase Protein Translation -- How to Design U1 snRNA Molecules for Splicing Rescue -- Conjugation of Nucleic Acids and Drugs to Gold Nanoparticles -- Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay -- Generation of Protein-Phosphorodiamidate Morpholino Oligomer Conjugates for Efficient Cellular Delivery via Anthrax Protective Antigen -- Development and Use of Cellular Systems to Assess and Correct Splicing Defects -- Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells -- In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin -- In Vitro Delivery of PMOs in Myoblasts by Electroporation -- Rapid Determination of MBNL1 Protein Levels by Quantitative Dot Blot for Evaluation of Antisense Oligonucleotides in Myotonic Dystrophy Myoblasts -- Evaluation of Exon Skipping and Dystrophin Restoration in In Vitro Models of Duchenne Muscular Dystrophy -- Generation of Human iPSC-Derived Myotubes to Investigate RNA-Based Therapies In Vitro -- Eye on a Dish Models to Evaluate Splicing Modulation -- Establishment of In Vitro Brain Models for AON Delivery -- Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides -- Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies -- Use of Small Animal Models for Duchenne and Parameters to Assess Efficiency upon Antisense Treatment -- In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin -- Delivery of Antisense Oligonucleotides to the Mouse Retina -- Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections -- Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System -- Preclinical Safety Assessment of Therapeutic Oligonucleotides -- Preclinical Evaluation of the Renal Toxicity of Oligonucleotide Therapeutics in Mice -- Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in Analyses of Hepatic Drug Distribution -- Patent Considerations When Embarking on New Antisense Drug Programs.…”
Link to Metadata
Electronic eBook -
300